An impedimetric assay of α-synuclein autoantibodies in early stage Parkinson's disease
Xu Q., Evetts S., Hu M., Talbot K., Wade-Martins R., Davis JJ.
A careful quantification of autoantibodies raised against the primary protein component of Lewy bodies enables a statistically significant differentiation between early stage Parkinson's patients and controls.